The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Refractory Status Epilepticus: Effect of Treatment Aggressiveness on Prognosis
Abstract
BACKGROUND: Administration of antiepileptic drugs for coma induction in refractory status epilepticus (RSE) has not been widely studied. Moreover, the effect on outcome of electroencephalographic (EEG) burst suppression remains unclear. OBJECTIVE: To investigate whether various coma-inducing options are associated with different prognoses after RSE. DESIGN: Retrospectively assessed case series. SETTING: Two tertiary referral hospitals in Boston, Mass. PATIENTS: Among 127 consecutive episodes (107 patients) of status epilepticus, we identified episodes that were refractory to first-line and second-line antiepileptic drugs, needing induced coma with barbiturates, propofol, or midazolam for clinical management. MAIN OUTCOME MEASURES: Short-term mortality and prevalence of return to functional baseline after the acute episode of status epilepticus were analyzed in relation to demographic and clinical variables and to treatment option (antiepileptic agents and EEG burst suppression). RESULTS: Forty-nine episodes of RSE (47 patients) were found, occurring more frequently in incident than in recurrent episodes of status epilepticus (P = .06). Mortality was 23% for patients with RSE and 8% for those without RSE (P = .05). Return to baseline occurred more often in the non-RSE group (P = .04). In 20 (61%) of 33 monitored episodes, EEG burst suppression was achieved. Demographic data, clinical variables, and outcome did not differ significantly with the various coma-inducing agents or between episodes with and without EEG burst suppression. CONCLUSIONS: Refractory status epilepticus is more prevalent in incident than in recurrent status epilepticus and is associated with higher mortality; clinical status is less likely to return to baseline than with non-RSE. Outcome was independent of the specific coma-inducing agents used and the extent of EEG burst suppression, suggesting that the underlying cause represents its main determinant.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579
A Comparison of Four Treatments for Generalized Convulsive Status Epilepticus
Treiman, D. M., Meyers, P. D., Walton, N. Y., Collins, J. F., Colling, C., Rowan, A. J., Handforth, A., Faught, E., Calabrese, V. P., Uthman, B. M., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809173391202 · Cited by 1,325
Guidelines for epidemiologic studies on epilepsy
Prognosis (1993) · Epilepsia · Cited by 1,183
A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia
DeLorenzo, R. J., Hauser, W. A., Towne, A. R., Boggs, J. G., Pellock, J. M., Penberthy, L., Garnett, L., Fortner, C. A., & Ko, D. (1996) · Neurology · doi:10.1212/wnl.46.4.1029 · Cited by 1,060
Treiman, D. M. (1996) · PubMed · Cited by 1,024
Alldredge, B. K., Gelb, A. M., Isaacs, S. M., Corry, M. D., Allen, F., Ulrich, S., Gottwald, M. D., O'Neil, N., Neuhaus, J. M., Segal, M. R., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa002141 · Cited by 888
Refractory Status Epilepticus: Frequency, Risk Factors, and Impact on Outcome
Mayer, S. A., Claassen, J., Lokin, J., Mendelsohn, F., Dennis, L. J., & Fitzsimmons, B.-F. (2002) · Archives of Neurology · doi:10.1001/archneur.59.2.205 · Cited by 658
Claassen, J., Hirsch, L. J., Emerson, R. G., & Mayer, S. A. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.28501.x · Cited by 642
The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome
Vasile, B., Rasulo, F., Candiani, A., & Latronico, N. (2003) · Intensive Care Medicine · doi:10.1007/s00134-003-1905-x · Cited by 568
Holtkamp, M. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.041947 · Cited by 403
Cited by
Guidelines for the Evaluation and Management of Status Epilepticus
Neurocritical Care Society Status Epilepticus Guideline Writing Committee, Brophy, G. M., Bell, R., Claassen, J., Alldredge, B., Bleck, T. P., Glauser, T., LaRoche, S. M., Riviello, J. J., Shutter, L., et al. (2012) · Neurocritical Care · doi:10.1007/s12028-012-9695-z · Cited by 1,623
Shorvon, S., & Ferlisi, M. (2011) · Brain · doi:10.1093/brain/awr215 · Cited by 685
Claassen, J., Taccone, F. S., Horn, P., Holtkamp, M., Stocchetti, N., & Oddo, M. (2013) · Intensive Care Medicine · doi:10.1007/s00134-013-2938-4 · Cited by 456
EFNS guideline on the management of status epilepticus in adults
Meierkord, H., Boon, P., Engelsen, B., Göcke, K., Shorvon, S., Tinuper, P., & Holtkamp, M. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02917.x · Cited by 433
Refractory status epilepticus: A prospective observational study
Novy, J., Logroscino, G., & Rossetti, A. O. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2009.02323.x · Cited by 347
Self-citation
Metadata
- Authors
- Rossetti, A. O., Logroscino, G., & Bromfield, E. B.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2005-11-01
- Volume
- 62
- Issue
- 11
- Pages
- 1698
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W1994421931
- Cited by
- 341
- References
- 21
- FWCI
- 7.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Refractory Status Epilepticus: Effect of Treatment Aggressiveness on Prognosis. https://app.cochat.ai/papers/10.1001/archneur.62.11.1698
- The paper
- Rossetti, A. O., Logroscino, G., & Bromfield, E. B. (2005). Refractory Status Epilepticus: Effect of Treatment Aggressiveness on Prognosis. Archives of Neurology. https://doi.org/10.1001/archneur.62.11.1698
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.